Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
I Am Recovery LLC, located in Pleasant Grove, UT, offers extensive support for individuals navigating the path to sobriety and stable living. They provide tailored programs for adults and adolescents, specifically addressing combined substance use and mental health challenges. Services include structured outpatient and intensive day treatment, utilizing proven methods such as cognitive behavioral therapy and emotional regulation techniques. Distinctive offerings are available for active duty service members, adult men, and women. At I Am Recovery LLC, clients receive personalized, high-quality assistance in a nurturing setting conducive to recovery and personal growth.
Situated in Rio Rancho, NM, Icarus Behavioral Health provides an extensive variety of treatment options for both adults and young adults facing challenges related to substance abuse and concurrent mental health conditions. The center emphasizes various forms of care, including long-term, short-term, and around-the-clock residential programs. It offers targeted services such as anger management, cognitive behavioral therapy, and short-term interventions. Distinctive programs designed for adult men, adult women, and those with co-occurring disorders guarantee customized and effective treatment. Icarus Behavioral Health is recognized for its dedication to high-quality care and a personalized strategy to support individuals in achieving sustained recovery.
The INSynergy Treatment Program located in Saint Louis, MO, offers an extensive variety of outpatient services aimed at detoxification, substance use recovery, and managing co-existing mental health issues in adults, alongside emotional challenges in children. This program features targeted outpatient detox services and options for methadone/buprenorphine treatment. Emphasizing anger management, brief interventions, and cognitive behavioral therapy, the facility serves adult men and women, including those with dual diagnoses of mental health and substance use disorders. Committed to providing exceptional care in a nurturing and welcoming atmosphere, INSynergy Treatment Program supports individuals of all ages and genders, including adults, children, and teenagers.
Situated in Muncie, IN, IU Health Ball is a premier rehabilitation facility that focuses on detox and treatment for substance use disorders. The center offers a range of services, including intensive outpatient therapy, standard outpatient programs, and outpatient detox. With an emphasis on customized care, IU Health Ball employs various methods, such as 12-step approaches, anger management, and brief interventions. Catering to both adults and youth, the facility provides services for both males and females, ensuring tailored treatment plans. IU Health Ball is committed to delivering exceptional support to guide individuals through their recovery process.
INSPIRA Behavioral Care Corp, located in Caguas, PR, presents a variety of outpatient programs designed for adults and minors grappling with substance abuse and dual mental health disorders. The center features specialized options for active military members, teenagers, and adult males, adopting a holistic approach to recovery. By employing scientifically supported strategies such as cognitive behavioral therapy, anger management, and brief intervention, the facility guarantees customized care for all clients. Individuals can choose from outpatient day treatment, partial hospitalization, or medication-assisted treatment, all benefiting from high-quality, gender-sensitive services. INSPIRA Behavioral Care Corp distinguishes itself through its dedication to delivering impactful, individualized rehabilitation support within a nurturing atmosphere.
Situated in Akron, Ohio, IBH Addiction Recovery delivers thorough care for substance use disorders and provides targeted interventions for individuals facing dual diagnoses of mental health conditions. They feature intensive outpatient, standard outpatient, and day treatment modalities, employing proven therapeutic techniques like 12-step support and emotional regulation strategies. Emphasizing a trauma-sensitive approach, IBH Addiction Recovery serves adults of all genders and young adults. Patients receive individualized care plans and high-quality support within a nurturing setting designed to meet their specific requirements.
ITRS Outpatient, located in Lansing, MI, delivers extensive rehabilitation services aimed at adults and children facing challenges related to substance use disorders and concurrent mental health issues. The center implements intensive outpatient programs that utilize proven methods such as cognitive behavioral therapy and motivational interviewing. ITRS Outpatient excels in addressing the needs of individuals with intricate circumstances, including those within the criminal justice system, offering personalized treatment plans. With specialized programs for both adults and youth, the facility is dedicated to providing exceptional, gender-sensitive care that fosters sustainable recovery and enhances overall health.
This Hutchinson, Kansas, treatment center, including a mobile unit, focuses on outpatient buprenorphine treatment for opioid use disorder. Programs serve adult women, pregnant and postpartum women, adult men, criminal justice clients, and people with co-occurring disorders or trauma histories. Federal funding, Medicare, Medicaid, TRICARE, SAMHSA block grants, and private insurance are accepted.
Hybrid Behavioral Health in Saint Paul, Minnesota, combines outpatient detoxification, intensive outpatient treatment, and medication services using buprenorphine and naltrexone, with transitional housing also available. Programs serve adult women, adult men, and criminal justice clients. Medicaid, state-financed plans, and private insurance are accepted.
Residential detoxification and short-term residential substance use treatment are available at this Middle River, Maryland facility, with buprenorphine and naltrexone used in care. Programs serve adult women and men, including those with co-occurring disorders. Medicaid, private insurance, and Spanish-language services are offered.
This Upper Marlboro, Maryland center offers a full continuum from residential detoxification through long-term residential care, partial hospitalization, and intensive outpatient treatment. Buprenorphine and naltrexone are used, and programs address co-occurring mental health disorders. Payment is limited to private insurance and self-pay.
In Tampa, Florida, Ibis Healthcare's Medication Assisted Treatment Program pairs outpatient care with short-term and long-term residential treatment, using methadone, buprenorphine, and naltrexone. Programming serves pregnant women, veterans, forensic clients, and people with HIV or AIDS. Medicaid, SAMHSA block grants, and sliding fees are accepted, with Spanish and sign language services.
Ibis Healthcare's Outpatient and Medication Assisted Treatment site in Lakeland, Florida, uses methadone, buprenorphine, and naltrexone to treat opioid use disorder in adults. Programming covers pregnant women, veterans, forensic clients, and trauma survivors. Medicaid, SAMHSA block grants, payment assistance, and sliding fees are accepted, with Spanish and sign language services.
IDCC Coney Island, a certified community behavioral health clinic in Brooklyn, New York, combines outpatient detoxification, intensive outpatient care, and medication treatment with buprenorphine or naltrexone. Programs serve children through seniors, including veterans and clients with HIV or AIDS. Medicaid, SAMHSA block grants, and federal funding are accepted, with services in Spanish, Chinese, Russian, and other languages.
The IM Sulzbacher Center for Homeless in Jacksonville, Florida, provides outpatient substance use treatment with buprenorphine and naltrexone for adults. Medicaid, Medicare, TRICARE, and payment assistance are accepted, along with a sliding fee scale based on income.
Situated in North Hollywood, California, IADARP provides diverse substance abuse recovery services customized for each person. This establishment offers intensive outpatient, standard outpatient, and step-down outpatient programs for adults and young adults, welcoming all genders. Emphasizing 12-step principles, rapid intervention, and cognitive behavioral strategies, IADARP guarantees a thorough path to healing. A distinctive feature of this center is its dedication to one-on-one client support through its individualized care model. For those in search of effective addiction treatment within a nurturing setting, IADARP stands out as a potential fit.
The IL Institute for Addiction Recovery, situated in Peoria, IL, provides extensive support for individuals battling addiction. Their specialized services include hospital-based inpatient detoxification and treatment for various substance use disorders. Employing evidence-based strategies such as 12-step facilitation, cognitive behavioral therapy, and brief interventions, they deliver tailored care to adult men and women. Distinctive programs are available for those who have faced intimate partner or domestic violence. This center also offers gender-specific treatment for both adult and young adult female and male patients. Committed to high-quality, individualized recovery plans, the IL Institute for Addiction Recovery is devoted to fostering long-term healing.
ICAN Community Services Inc, situated in South Holland, IL, delivers thorough substance abuse care for adults and young adults. The facility offers intensive outpatient programs, general outpatient services, and medication-assisted treatment utilizing methadone, buprenorphine, or naltrexone. Their approach incorporates brief intervention, cognitive behavioral therapy, and relapse prevention strategies, with personalized treatment plans for each individual. Specialized support is available for adolescents, adult men, and adult women. ICAN Community Services Inc is dedicated to providing high-quality treatment for all clients, serving as a key provider for addiction recovery in the South Holland community.
Situated in Lawrenceburg, IN, INcompass Healthcare specializes in treating adults and children dealing with substance use disorders alongside significant mental health challenges. The center offers various outpatient services, such as intensive outpatient programs and partial hospitalization, designed to meet diverse needs. INcompass Healthcare employs proven methods including 12-step facilitation, anger management, and brief interventions to aid individuals in their recovery process. With an emphasis on personalized treatment, the facility serves adults and seniors of all genders, crafting specific plans that cater to each client’s unique situation. Discover empathetic and all-encompassing support at INcompass Healthcare.
INcompass Healthcare, located in Lawrenceburg, IN, provides tailored recovery programs for individuals grappling with addiction and associated mental health challenges, serving both adolescents and adults. Their approach encompasses a spectrum of care, from intensive inpatient hospital stays to sustained residential living, all designed with personalization at its core for men, women, and seniors. Employing proven therapeutic techniques like 12-step support, emotional regulation training, and concise counseling, INcompass Healthcare guarantees advanced treatment strategies adapted to the unique journey of each patient. For a supportive and successful path to healing, INcompass Healthcare is committed to delivering excellent services for enduring sobriety.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.